Dr. Reddy’s Laboratories has reported results for second quarter ended September 30, 2018.
The company has reported over 3 fold jump in its net profit at Rs 346.20 crore for the quarter under review as compared to Rs 100.70 crore for the same quarter in the previous year. Total income of the company increased by 17.92% at Rs 2,705.80 crore for Q2FY19 as compared Rs 2,294.70 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 69.71% in its net profit after taxed and share of profit of associates at Rs 518.30 crore for the quarter under review as compared to Rs 305.40 crore for the same quarter in the previous year. Total income of the company increased by 9.87% at Rs 3,945.70 crore for Q2FY19 as compared Rs 3,591.40 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1507.00 |
Dr. Reddys Lab | 6037.55 |
Cipla | 1497.30 |
Zydus Lifesciences | 1058.45 |
Lupin | 1630.90 |
View more.. |